spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PAQUETTE, C. A.
Right arrow Articles by HOUTEN, J. L. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PAQUETTE, C. A.
Right arrow Articles by HOUTEN, J. L. V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

GLYCOPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS IN PARAMECIUM TETRAURELIA : POSSIBLE ROLE IN CHEMORESPONSE

CARRIE A. PAQUETTE, VILLA RAKOCHY, ALISON BUSH and JUDITH L. VAN HOUTEN*

University of Vermont, Department of Biology, Burlington, VT 05405, USA
* Author for correspondence (e-mail: jvanhout{at}zoo.uvm.edu )



View larger version (45K):

[in a new window]
  		Fig. 6. Western blots to show that integral membrane proteins are not among those released by phospholipase C (PLC) or by washing the cells with salt/ethanol. (A) Positive and negative control western blots probed with anti-A and anti-B, anti-Ca2+-pump and anti-cyclic-AMP receptor antisera. m, pre-stained molecular mass markers. Lane 1, supernatant from PLC-treated pellicle; lanes 2, 4, bacterially expressed Ca2+ pump/glutathione-S-transferase (GST) fusion protein; lanes 3, 5, peptide from the N terminus of the cyclic AMP receptor/GST fusion protein expressed in bacteria. Lanes 1-3 were treated with anti-A and anti-B antisera, lane 4 with anti-Ca2+-pump antiserum and lane 5 with anti-cyclic-AMP receptor antiserum. The filled arrowhead points to surface antigen, and the open arrowhead points to 40-60 kDa proteins. The filled arrow marks the position of the Ca2+ pump/GST fusion protein and the open arrow to that of the N terminus of the cyclic AMP receptor/GST fusion protein. The proteins were separated on 12 % polyacrylamide gels. (B) Western blots of supernatants from sham- and PLC-treated pellicles developed with three different antibodies. m, prestained molecular mass markers. Lanes 1, 3, 5, sham-treatment supernatants; lanes 2, 4, 6, PLC treatment supernatants. Lanes 1 and 2 were treated with anti-Ca2+-pump (anti-cbd) antiserum, lanes 3 and 4 with anti-cyclic-AMP-receptor antiserum (cA rec) and lanes 5 and 6 with the anti-cross-reactive-determinant (anti-crd) antiserum. The filled arrowhead points to surface antigen, and the open arrowhead to 40-60 kDa proteins. The filled arrow points to where the intact Ca2+ pump from pellicle is expected to run (133 kDa). The open arrow points to 48 kDa, where the cyclic AMP receptor is expected to run. 6-12 % gradient polyacrylamide gels were used. (C) Western blots of salt/ethanol washes probed with three different antisera. Lane 1, anti-Ca2+-pump antiserum; lane 2, anti-A and anti-B antisera; lane 3, anti-cyclic-AMP-receptor antiserum. The filled arrow points to the expected molecular mass of the native Ca2+ pump, and the open arrow points to that of the native cyclic AMP receptor. Gradient gels from 6 to 12 % polyacrylamide were used.

 


View larger version (78K):

[in a new window]
  		Fig. 1. Phospholipase treatment removes proteins with glycophosphatidylinositol (GPI) anchors from Paramecium pellicles. (A) Western blot probed with anti-A and anti-B antisera. Lane 1, pellet of sham-treated pellicle; lane 2, supernatant of sham-treated pellicle; lane 3, pellet of inositol-phosphate-specific phospholipase C (PLC)-treated pellicle; lane 4, supernatant of PLC-treated pellicle. The filled arrow points to surface antigens. The open arrow points to 40-60 kDa proteins. (B) Western blot probed with anti-cross-reacting-determinant (anti-CRD) antiserum, which binds to the cleaved GPI anchor. Lanes as in A. Gradient gels contained 8 % polyacrylamide.

 


View larger version (78K):

[in a new window]
  		Fig. 2. Proteins removed from pellicle by phospholipase C (PLC) treatment at 37 and 0°C. (A) Western blot probed with anti-A and anti-B antisera, Lane 1, supernatant of sham-treated pellicle at 0°C; lane 2, supernatant of PLC-treated pellicle at 0°C; lane 3, supernatant of sham-treated pellicle at 37°C; lane 4, supernatant of PLC-treated pellicle at 37°C. (B) Same supernatants as in A but probed with anti-cross-reacting-determinant (anti-CRD) antiserum. The filled arrow points to surface antigens; the open arrow points to proteins of 40-60 kDa in gradient gels ranging from 6 to 12 % polyacrylamide.

 


View larger version (56K):

[in a new window]
  		Fig. 3. Different phospholipase C (PLC) inhibitors affect exogenous and endogenous lipase activities. (A) Western blot probed with anti-A and anti-B antisera. Lane 1, supernatant from sham-treated pellicle; lane 2, supernatant from PLC-treated pellicle; lane 3, supernatant from phospholipase C (PLC)-treated pellicle with 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC) and phenylmethanesulfonyl fluoride (PMSF); lane 4, supernatant of PLC-treated pellicle with p-chloromercuriphenylsulfonic acid (PCMPSA); lane 5, salt/ethanol wash proteins; lane 6, proteins from salt/ethanol wash in the presence of NCDC and PMSF; lane 7, proteins from salt/ethanol wash in the presence of PCMPSA. (B) Same as A but probed with anti-cross-reacting-determinant (anti-CRD) antiserum. The open arrow points to 40-60 kDa proteins. Surface antigens (>200 kDa) are best seen in lanes A2, A4, A5 and B2. Other proteins of interest are between 40 and 60 kDa. Gels were 8 % polyacrylamide.

 


View larger version (91K):

[in a new window]
  		Fig. 5. Triton X-114 extraction solubilizes glycophosphatidylinositol (GPI)-anchored proteins. (A) Western blot probed with anti-A and anti-B antisera. Lane 1, supernatant from phospholipase C (PLC)-treated pellicle; lane 2, supernatant from PLC-treated pellicle in the presence of 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate and phenylmethanesulfonyl fluoride; lane 3, aqueous phase of Triton X-114 extraction from phase separation of pellicle proteins; lane 4, proteins from the detergent phase of Triton X-114 extraction and phase separation of pellicle. (B) Anti-cross-reactive-determinant developed electroblot of the same samples as in A. The filled arrow points to surface antigens, and the open arrow to 40-60 kDa proteins. 8 % polyacrylamide gels were used.

 


View larger version (106K):

[in a new window]
  		Fig. 4. Phase-contrast micrographs of cells treated with salt/ethanol wash. (A) Typical cell treated with Dryl's solution before fixation and microscopy. (B) Typical cell treated with salt/ethanol before fixation and microscopy showing no loss of cilia. Scale bar, 10µm.

 


View larger version (30K):

[in a new window]
  		Fig. 7. Western blot of salt/ethanol wash proteins showing a band reactive with antiserum against a glycophosphatidylinositol (GPI)-anchored folate receptor and reactive with anti-cross-reactive-determinant antiserum. Lane 1, treated with antifolate-binding-protein antiserum. The protein band at the arrow has an approximate molecular mass of 37 kDa. Lane 2, treated with anti-cross-reactive-determinant antiserum. Note that a band at the same molecular mass, 37 kDa, is recognized. Gels contained 12% polyacrylamide.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



© The Company of Biologists Ltd 2001